Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core approval, scheduling and reimbursement hurdles in place. President Donald Trump on April 18 signed an executive order directing federal agencies to speed review, research, and access pathways for psychedelic drugs, with a focus on serious mental illness and veteran […] The post Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways appeared first on Psychedelics Today.
External link. We are not responsible for the content.
Read more ↗More From Psychedelics Today
Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols
What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West ...
A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter
Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with ...
Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy
Dr. Michael Alpert and Peter Alberding discuss ALS, ketamine-assisted psychotherapy, end-of-life fear, music, trust, ...
Latest News
Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion
Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.
5 Things We Learned at Psychedelic Culture 2026
Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at P...
Global Altered States: The Storefront Psychedelic
This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.
Psychonautisme, Herbes et Suppléments
De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la n...
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements fro...
Evaluating the Pros and Cons of State Psychedelic Task Forces
While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psych...